AllianceBernstein’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.1M | Sell |
4,129,687
-212,264
| -5% | -$2.02M | 0.02% | 591 |
|
|
2025
Q4 | $52.7M | Buy |
4,341,951
+917,512
| +27% | +$11.1M | 0.02% | 610 |
|
|
2025
Q3 | $40M | Buy |
3,424,439
+3,261,619
| +2,003% | +$39M | 0.01% | 678 |
|
|
2025
Q2 | $1.51M | Hold |
162,820
| – | – | ﹤0.01% | 2074 |
|
|
2025
Q1 | $1.19M | Hold |
162,820
| – | – | ﹤0.01% | 2155 |
|
|
2024
Q4 | $1.39M | Hold |
162,820
| – | – | ﹤0.01% | 2151 |
|
|
2024
Q3 | $1.42M | Hold |
162,820
| – | – | ﹤0.01% | 2147 |
|
|
2024
Q2 | $1.11M | Buy |
162,820
+57,870
| +55% | +$357K | ﹤0.01% | 2240 |
|
|
2024
Q1 | $955K | Buy |
104,950
+10,600
| +11% | +$75.2K | ﹤0.01% | 2293 |
|
|
2023
Q4 | $421K | Hold |
94,350
| – | – | ﹤0.01% | 2694 |
|
|
2023
Q3 | $296K | Buy |
94,350
+5,750
| +6% | +$23.5K | ﹤0.01% | 2815 |
|
|
2023
Q2 | $457K | Sell |
88,600
-4,900
| -5% | -$29.1K | ﹤0.01% | 2688 |
|
|
2023
Q1 | $493K | Hold |
93,500
| – | – | ﹤0.01% | 2583 |
|
|
2022
Q4 | $263K | Buy |
93,500
+7,100
| +8% | +$23.5K | ﹤0.01% | 2911 |
|
|
2022
Q3 | $359K | Sell |
86,400
-5,300
| -6% | -$26.7K | ﹤0.01% | 2792 |
|
|
2022
Q2 | $369K | Buy |
91,700
+4,900
| +6% | +$18.5K | ﹤0.01% | 2811 |
|
|
2022
Q1 | $430K | Buy |
86,800
+200
| +0.2% | +$1.11K | ﹤0.01% | 2742 |
|
|
2021
Q4 | $604K | Hold |
86,600
| – | – | ﹤0.01% | 2654 |
|
|
2021
Q3 | $866K | Hold |
86,600
| – | – | ﹤0.01% | 2545 |
|
|
2021
Q2 | $1.23M | Hold |
86,600
| – | – | ﹤0.01% | 2443 |
|
|
2021
Q1 | $1.42M | Buy |
86,600
+2,200
| +3% | +$42.4K | ﹤0.01% | 2262 |
|
|
2020
Q4 | $1.75M | Buy |
84,400
+4,000
| +5% | +$59.4K | ﹤0.01% | 2062 |
|
|
2020
Q3 | $612K | Hold |
80,400
| – | – | ﹤0.01% | 2429 |
|
|
2020
Q2 | $670K | Sell |
80,400
-12,200
| -13% | -$80.9K | ﹤0.01% | 2428 |
|
|
2020
Q1 | $458K | Buy |
92,600
+34,700
| +60% | +$171K | ﹤0.01% | 2399 |
|
|
2019
Q4 | $229K | Hold |
57,900
| – | – | ﹤0.01% | 2878 |
|
|
2019
Q3 | $176K | Sell |
57,900
-4,600
| -7% | -$20.6K | ﹤0.01% | 2973 |
|
|
2019
Q2 | $275K | Buy |
62,500
+14,800
| +31% | +$54.8K | ﹤0.01% | 2857 |
|
|
2019
Q1 | $189K | Sell |
47,700
-3,400
| -7% | -$13.7K | ﹤0.01% | 2915 |
|
|
2018
Q4 | $203K | Hold |
51,100
| – | – | ﹤0.01% | 2885 |
|
|
2018
Q3 | $352K | Buy |
51,100
+4,100
| +9% | +$25.7K | ﹤0.01% | 2773 |
|
|
2018
Q2 | $317K | Buy |
47,000
+2,600
| +6% | +$17.9K | ﹤0.01% | 2792 |
|
|
2018
Q1 | $289K | Hold |
44,400
| – | – | ﹤0.01% | 2712 |
|
|
2017
Q4 | $198K | Buy |
44,400
+2,700
| +6% | +$13.8K | ﹤0.01% | 2875 |
|
|
2017
Q3 | $258K | Hold |
41,700
| – | – | ﹤0.01% | 2826 |
|
|
2017
Q2 | $387K | Buy |
41,700
+14,400
| +53% | +$139K | ﹤0.01% | 2706 |
|
|
2017
Q1 | $253K | Hold |
27,300
| – | – | ﹤0.01% | 2777 |
|
|
2016
Q4 | $229K | Hold |
27,300
| – | – | ﹤0.01% | 2843 |
|
|
2016
Q3 | $188K | Hold |
27,300
| – | – | ﹤0.01% | 2851 |
|
|
2016
Q2 | $135K | Buy |
27,300
+15,300
| +128% | +$152K | ﹤0.01% | 2874 |
|
|
2016
Q1 | $116K | Sell |
12,000
-69,260
| -85% | -$525K | ﹤0.01% | 2805 |
|
|
2015
Q4 | $761K | Buy |
81,260
+22,716
| +39% | +$245K | ﹤0.01% | 2266 |
|
|
2015
Q3 | $823K | Buy |
58,544
+46,544
| +388% | +$935K | ﹤0.01% | 2269 |
|
|
2015
Q2 | $252K | Buy |
12,000
+7,600
| +173% | +$188K | ﹤0.01% | 2800 |
|
|
2015
Q1 | $185K | Buy |
+4,400
| New | +$145K | ﹤0.01% | 2857 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
